Alfa Wassermann Separation Technologies
Scott Glanzman is an experienced marketing and sales professional with a robust background in the healthcare and laboratory industries. Currently serving as Vice President of Global Marketing at Alfa Wassermann Separation Technologies since December 2014, Scott previously held several leadership roles, including Vice President at McKesson Medical Surgical, where responsibility encompassed sales in the physician office and surgery center markets. Scott also led sales efforts at Fisher Scientific and directed marketing at Roche Diagnostics. Earlier career achievements include serving as Vice President and General Manager at Wampole Laboratories, where notable success was achieved in integrating acquired companies to establish market leadership in autoimmune and infectious disease testing. Scott holds two Bachelor of Science degrees in Education from Indiana University Bloomington, focusing on Biology/General Science and Secondary Education.
This person is not in any teams
This person is not in any offices
Alfa Wassermann Separation Technologies
Alfa Wassermann Separation Technologies, a division of Alfa Wassermann Inc. (AWI), is the leader in ultracentrifugation solutions for process development and industrial scale manufacturing in design, manufacture and service of continuous flow ultracentrifuges. AWST ultracentrifuges are used efficiently and reliably for separation, fractionation and concentration of viral vectors, virus-like particles, viruses, viral and bacterial vaccines, macromolecules and cellular organelles for development and manufacture of vaccines and bio-products. From protocol development to pilot scale to industrial scale production, our systems meet cGMP requirements. A range of rotors allow batch and continuous flow operations with process volumes of up to two hundred liters. Scalable rotors allow protocol development with Promatix 1000™ Ultracentrifuge to be scaled-up to the KII Ultracentrifuge while retaining similar recovery and critical process parameters. With the addition of the AWST Automated Fluid Handling (AFH), customers now can have a system that fully automates and standardizes critical bio-manufacturing processes.